Litcius/Paper detail

Benefits and drawbacks of statins and non-statin lipid lowering agents in carotid artery disease

Kosmas I. Paraskevas, Péter Gloviczki, Pier Luigi Antignani, Anthony J. Comerota, Alan Dardik, Alun H. Davies, Hans‐Henning Eckstein, Gianluca Faggioli, José Fernandes e Fernandes, Gustav Fraedrich, George Geroulakos, Jonathan Golledge, Ajay Gupta, В. С. Гуревич, Arkadiusz Jawień, Mateja K. Ježovnik, Stavros K. Kakkos, Michael Knoflach, Gaetano Antonio Lanza, Christos D. Liapis, Ian Loftus, Armando Mansilha, Andrew Nicolaides, Rodolfo Pini, Pavel Poredoš, Robert M. Proczka, Jean‐Baptiste Ricco, Tatjana Rundek, Luca Saba, Felix Schlachetzki, Mauro Silvestrini, Francesco Spinelli, Francesco Stilo, Jasjit S. Suri, А. В. Светликов, Clark J. Zeebregts, Seemant Chaturvedi, Frank J. Veith, Dimitri P. Mikhailidis

2022Progress in Cardiovascular Diseases34 citationsDOIOpen Access PDF

Topics & Concepts

MedicineEzetimibeStatinPCSK9Stroke (engine)Internal medicineCardiologyCoronary artery diseaseCholesterolPharmacologyLipoproteinLDL receptorEngineeringMechanical engineeringCerebrovascular and Carotid Artery DiseasesLipoproteins and Cardiovascular HealthProtease and Inhibitor Mechanisms
Benefits and drawbacks of statins and non-statin lipid lowering agents in carotid artery disease | Litcius